1
Materials and methods: Twenty patients with high-grade gliomas prospectively underwent diffusion- weighted MRI.
2
Additionally, dark-blood T2- weighted MRI may underestimate area at risk and myocardial salvage.
3
Contrast-enhanced T1- weighted MRI and diffusion-weighted imaging are useful tools for assessing treatment.
4
The high signal intensity in both ganglia in T2- weighted MRI also disappeared.
5
Conventional and perfusion- weighted MRI were performed in every 4 weeks.
6
The SPIO-enhanced T2- weighted MRI analyzed whether the signal intensity of each nodule was high.
7
Source localization was visualized by superposition on T1- weighted MRI and compared to the lesion.
8
We show that DT-MRI is more sensitive than T2- weighted MRI in detecting Wallerian degeneration.
9
Diffusion- weighted MRI (DWI) is becoming important for diagnosis and investigation of acute cerebral ischaemia.
10
High-resolution proton- weighted MRI in 3 planes was used.
11
Conclusion: Intravoxel incoherent motion diffusion- weighted MRI can be used to differentiate between nodular HHBM and malignant VBML.
12
A phantom study was used to assess the efficacy of PASP-IO as a T2- weighted MRI contrast agent.
13
Conclusions: Bright-blood T2- weighted MRI has higher diagnostic accuracy than dark-blood T2-weighted MRI.
14
Axial T(2)- weighted MRI scans were examined for the presence and severity of white matter abnormalities.
15
Purpose: Diffusion- weighted MRI is sensitive to incoherent tissue motion, which may confound the measured signal and subsequent analysis.
16
Objective: To evaluate the whole body MRI and diffusion- weighted MRI in detecting intranodal lesions in patients with lymphoma.